Delhi police arrests Leena Maria Paul for duping Ranbaxy ex-founder's wife of Rs 200 crore
The police have invoked the stringent Maharashtra Control of Organised Crime (MCOCA) Act against the accused, a senior police officer said, adding that further investigation into the matter is underway.
Sep 06, 2021, 12:53 PM IST
Delhi HC reserves order on Ranbaxy ex-promoter Malvinder Singh's plea against seeking quashing of FIR
Malvinder Mohan Singh, who was arrested on Thursday, had earlier today moved the court seeking quashing of the case registered against him. The EOW has also arrested his brother Shivinder, Sunil Godhwani, who is a former MD of Religare, Kavi Arora and Sunil Saxena in a separate case.
Oct 11, 2019, 14:35 PM IST
Former Ranbaxy promoter Shivinder Mohan Singh arrested in Rs 700 crore fraud case
It may be recalled that Shivinder Mohan Singh and Malvinder Mohan Singh were booked by Economics Offence Wing of Delhi Police in March 2019 on charges of cheating, criminal conspiracy and breach of trust related to Religare Enterprises and its subsidiary Religare Finvest Limited (RFL).
Oct 10, 2019, 18:02 PM IST
ED conducts raids at residences of Ranbaxy group promoters Malvinder, Shivinder Singh
Singh brothers were booked in March on charges of cheating, criminal conspiracy and breach of trust related to Religare Enterprises and its subsidiary Religare Finvest Limited (RFL).
Aug 01, 2019, 14:38 PM IST
We will send you to jail: SC to ex-Ranbaxy promoters
The court was hearing a petition filed by Daiichi Sankyo, which is seeking to recover Rs 3,500 crore awarded to it in an arbitration by a Singapore tribunal against the Ranbaxy brothers.
Apr 05, 2019, 17:05 PM IST
SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 cr arbitral award
The bench asked the Singh brothers to appear before it on March 28 and submit the plan.
Mar 14, 2019, 12:03 PM IST
Prices of 56 drugs to come down; NPPA fixes ceiling rates
Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Jun 06, 2016, 17:51 PM IST
Sun Pharma withdraws suit filed by Ranbaxy against USFDA
The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US.
Oct 09, 2015, 14:54 PM IST
Strides Arcolab shares up 4% on Sun Pharma deal
Shares of Strides Arcolab rose by 4 percent Monday as it entered into a pact with Sun Pharma to buy from it erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India for Rs 165 crore.
Sep 21, 2015, 13:27 PM IST
Sun Pharma to sell Ranbaxy's 2 CNS divisions to Strides for Rs 165 crore
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.
Sep 19, 2015, 15:13 PM IST
Nifty tumbles 74 points on frantic selling; pharma stocks tank
The broader 50-share NSE Nifty opened higher at 8,601.50 and fluctuated between a high of 8,646.75 and low of 8,517.90 before ending at 8,529.45, a sharp fall of 74 points, or 0.86 percent.
Jul 21, 2015, 19:46 PM IST
Sun Pharma asks 18 top brass of Ranbaxy to resign
This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.
Jun 18, 2015, 12:23 PM IST
Focus on getting Ranbaxy's plants USFDA nod one at a time: Sun Pharma
The Mumbai-based drug major, which acquired Ranbaxy in a USD 4 billion deal, feels it is important for the merged entity to "re-establish" the trust between Ranbaxy and the US Food and Drug Administration (USFDA).
Jun 07, 2015, 14:41 PM IST
Daiichi Sankyo exits Sun Pharma; ends 7 years of tumultuous ride in India
The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.
Apr 21, 2015, 14:42 PM IST
Sun Pharma shares tank 11% as Daiichi completes exit
Shares of Sun Pharmaceutical on Tuesday plunged nearly 11 percent after Japan's Daiichi Sankyo announced selling its entire holding in the Indian drug major for an estimated Rs 20,420 crore.
Apr 21, 2015, 13:46 PM IST
Sun Pharma slumps most in near six years on Daiichi's share sale
Shares of Sun Pharmaceutical Industries Ltd slumped as much as 10.9 percent on Tuesday, heading towards their biggest daily fall since June 2009 after Japan`s Daiichi Sankyo Co Ltd started selling its stake in the Indian drugmaker.
Apr 21, 2015, 10:15 AM IST
Sensex surges 302 points; logs 1st weekly gain in three weeks
The 50-share NSE Nifty also rose by 95.25 points or 1.12 percent, to 8,586.25 after hitting today's high of 8,603.40.
Apr 01, 2015, 17:14 PM IST
BSE to discontinue trading in Ranbaxy from April 6
The BSE has decided to delist Ranbaxy scrip from S&P BSE 100, S&P BSE 200, S&P BSE 500, S&P BSE Healthcare and S&P BSE Carbonex indices from April 6.
Mar 27, 2015, 21:19 PM IST
Sun Pharma, Ranbaxy rise after regulatory nods for merger deal
At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.
Mar 24, 2015, 17:33 PM IST
Sun Pharma, Ranbaxy rise after regulatory nods for merger deal
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories today settled in the positive territory after regulatory nods paved the way for completion of their USD 4-billion merger.
Mar 24, 2015, 17:20 PM IST
